Molecular understanding of curcumin in diabetic nephropathy

Vivian Soetikno, Kenji Suzuki, Punniyakoti T. Veeraveedu, Somasundaram Arumugam, Arun Lakshmanan, Hirohito Sone, Kenichi Watanabe

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Diabetic nephropathy is characterized by a plethora of signaling abnormalities. Recent trials have suggested that intensive glucose-lowering treatment leads to hypoglycemic events, which can be dangerous. Curcumin is the active ingredient of turmeric, which has been widely used in many countries for centuries to treat numerous diseases. The preventive and therapeutic properties of curcumin are associated with its antioxidant and anti-inflammatory properties. Here, we highlight the renoprotective role of curcumin in diabetes mellitus (DM) with an emphasis on the molecular basis of this effect. We also briefly discuss the numerous approaches that have been undertaken to improve the pharmacokinetics of curcumin.

Original languageEnglish
Pages (from-to)756-763
Number of pages8
JournalDrug Discovery Today
Volume18
Issue number15-16
DOIs
Publication statusPublished - 1 Aug 2013
Externally publishedYes

Fingerprint

Curcumin
Diabetic Nephropathies
Curcuma
Hypoglycemic Agents
Diabetes Mellitus
Anti-Inflammatory Agents
Pharmacokinetics
Antioxidants
Glucose
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Soetikno, V., Suzuki, K., Veeraveedu, P. T., Arumugam, S., Lakshmanan, A., Sone, H., & Watanabe, K. (2013). Molecular understanding of curcumin in diabetic nephropathy. Drug Discovery Today, 18(15-16), 756-763. https://doi.org/10.1016/j.drudis.2013.04.009

Molecular understanding of curcumin in diabetic nephropathy. / Soetikno, Vivian; Suzuki, Kenji; Veeraveedu, Punniyakoti T.; Arumugam, Somasundaram; Lakshmanan, Arun; Sone, Hirohito; Watanabe, Kenichi.

In: Drug Discovery Today, Vol. 18, No. 15-16, 01.08.2013, p. 756-763.

Research output: Contribution to journalReview article

Soetikno, V, Suzuki, K, Veeraveedu, PT, Arumugam, S, Lakshmanan, A, Sone, H & Watanabe, K 2013, 'Molecular understanding of curcumin in diabetic nephropathy', Drug Discovery Today, vol. 18, no. 15-16, pp. 756-763. https://doi.org/10.1016/j.drudis.2013.04.009
Soetikno V, Suzuki K, Veeraveedu PT, Arumugam S, Lakshmanan A, Sone H et al. Molecular understanding of curcumin in diabetic nephropathy. Drug Discovery Today. 2013 Aug 1;18(15-16):756-763. https://doi.org/10.1016/j.drudis.2013.04.009
Soetikno, Vivian ; Suzuki, Kenji ; Veeraveedu, Punniyakoti T. ; Arumugam, Somasundaram ; Lakshmanan, Arun ; Sone, Hirohito ; Watanabe, Kenichi. / Molecular understanding of curcumin in diabetic nephropathy. In: Drug Discovery Today. 2013 ; Vol. 18, No. 15-16. pp. 756-763.
@article{6cb3053c28d5405785eb12e8d85cae61,
title = "Molecular understanding of curcumin in diabetic nephropathy",
abstract = "Diabetic nephropathy is characterized by a plethora of signaling abnormalities. Recent trials have suggested that intensive glucose-lowering treatment leads to hypoglycemic events, which can be dangerous. Curcumin is the active ingredient of turmeric, which has been widely used in many countries for centuries to treat numerous diseases. The preventive and therapeutic properties of curcumin are associated with its antioxidant and anti-inflammatory properties. Here, we highlight the renoprotective role of curcumin in diabetes mellitus (DM) with an emphasis on the molecular basis of this effect. We also briefly discuss the numerous approaches that have been undertaken to improve the pharmacokinetics of curcumin.",
author = "Vivian Soetikno and Kenji Suzuki and Veeraveedu, {Punniyakoti T.} and Somasundaram Arumugam and Arun Lakshmanan and Hirohito Sone and Kenichi Watanabe",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.drudis.2013.04.009",
language = "English",
volume = "18",
pages = "756--763",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "15-16",

}

TY - JOUR

T1 - Molecular understanding of curcumin in diabetic nephropathy

AU - Soetikno, Vivian

AU - Suzuki, Kenji

AU - Veeraveedu, Punniyakoti T.

AU - Arumugam, Somasundaram

AU - Lakshmanan, Arun

AU - Sone, Hirohito

AU - Watanabe, Kenichi

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Diabetic nephropathy is characterized by a plethora of signaling abnormalities. Recent trials have suggested that intensive glucose-lowering treatment leads to hypoglycemic events, which can be dangerous. Curcumin is the active ingredient of turmeric, which has been widely used in many countries for centuries to treat numerous diseases. The preventive and therapeutic properties of curcumin are associated with its antioxidant and anti-inflammatory properties. Here, we highlight the renoprotective role of curcumin in diabetes mellitus (DM) with an emphasis on the molecular basis of this effect. We also briefly discuss the numerous approaches that have been undertaken to improve the pharmacokinetics of curcumin.

AB - Diabetic nephropathy is characterized by a plethora of signaling abnormalities. Recent trials have suggested that intensive glucose-lowering treatment leads to hypoglycemic events, which can be dangerous. Curcumin is the active ingredient of turmeric, which has been widely used in many countries for centuries to treat numerous diseases. The preventive and therapeutic properties of curcumin are associated with its antioxidant and anti-inflammatory properties. Here, we highlight the renoprotective role of curcumin in diabetes mellitus (DM) with an emphasis on the molecular basis of this effect. We also briefly discuss the numerous approaches that have been undertaken to improve the pharmacokinetics of curcumin.

UR - http://www.scopus.com/inward/record.url?scp=84881183241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881183241&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2013.04.009

DO - 10.1016/j.drudis.2013.04.009

M3 - Review article

VL - 18

SP - 756

EP - 763

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 15-16

ER -